Ask Advarra Live: The Real-World Impact of COVID-19 on Research
The unprecedented COVID-19 pandemic has quickly changed how we live and work. This extraordinary situation has resulted in a significant impact on IRB-approved protocols and research yet to go through…
IRB Review of Coronavirus and Other Emerging Infectious Disease Research: Issues to Consider
In this blog we discuss unique issues that research involving emerging infectious diseases like coronavirus can raise for IRB review and research informed consent.
Evaluating Payment to Participate in Research: Ethical and Regulatory Issues
Luke Gelinas, IRB Chairperson at Advarra, proposes a practical framework for evaluating offers of payment and applies it to case studies to yield guidance on challenging ethical and regulatory issues…
Are “Virtual Trials” Mainstream Yet?
While some completely virtual trials are taking place, the real trend involves bringing virtual trial components to traditional study designs to improve study efficiency and reduce participant burden.
How Institutions Gain Research Opportunities from Partnering with Multiple Independent IRBs
Academic medical centers (AMCs) and health systems across the US are attempting to win more industry-sponsored research trials, and one strategy is to partner with the multiple external IRBs that…
Advarra Integrates IRB with Veeva Vault eTMF, Delivers Unparalleled Efficiency for a Top 10 Biopharma
Teamwork and leadership from an industry-leading biopharmaceutical company and Advarra accomplish integration through Veeva Vault eTMF, saving over 8000 hours in the first 6 months.
Informed Consent: 6 Approaches to Increase Participant Comprehension
Ensuring participants have appropriate knowledge of a study is a crucial goal of the informed consent process. This paper describes six research-based approaches for improving informed consent and supporting participants’…
Managing Conflicts of Interest in Clinical Research
Managing conflicts of interest in clinical research is a critical mission for many reasons. Here we discuss the need for conflict of interest policies in clinical research, examine the specific…
Botanical Medicines in Research
Botanicals have been used for millennia to combat illness—but why are there so few clinical trials testing the merits of this modality? This whitepaper describes rationale for why IRBs should…